Skip to main content
ONC logo

BeOne Medicines AG

ONCNASDAQHealthcareBiotechnology

$373.36Today:- (-)1Y +23.30%

As of Oct 28, 2026 close

Market cap
$43.23B
P/E (TTM)
439.24
Forward P/E
-
Dividend yield
-
52-week range
$253.95$385.22
Volume (live)
-
Avg. volume (3M)
388.12K

BeOne Medicines (ONC) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), BeOne Medicines reported total assets of $8.19B and total liabilities of $3.83B. Shareholders' equity was $4.36B, up 30.9% from $3.33B a year earlier. Total debt stood at $2.00B against $4.55B in cash and short-term investments, a net cash position of $2.55B. That puts debt-to-equity at 0.46, compared with 0.32 a year earlier.

BeOne Medicines Balance Sheet Analysis

Values in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for BeOne Medicines AG (ONC) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents4.552.633.173.874.381.380.620.710.24
Short-Term Investments0.000.000.000.672.243.270.361.070.60
Cash & Short-Term Investments4.552.633.174.536.624.650.981.780.84
Accounts Receivable0.870.710.360.170.480.080.070.050.03
Inventory0.610.490.420.280.240.090.030.020.01
Other Current Assets0.210.160.040.220.270.140.090.100.04
Total Current Assets6.233.994.205.217.614.961.171.940.91
Non-Current Assets
Property, Plant & Equipment (Net)1.791.661.370.960.710.450.320.190.06
Long-Term Investments0.080.130.090.090.100.050.000.000.00
Goodwill0.000.000.000.000.000.000.000.000.00
Intangible Assets0.060.130.110.040.050.050.010.050.02
Other Non-Current Assets0.020.010.010.180.170.020.110.030.04
Total Non-Current Assets1.951.931.601.170.920.640.440.310.13
Total Assets8.195.925.816.388.545.601.612.251.05
Current Liabilities
Accounts Payable0.480.400.320.290.260.230.120.110.07
Short-Term Debt0.130.870.690.330.430.350.010.010.01
Current Portion of Long-Term Debt0.060.030.030.010.000.00---
Accrued Liabilities0.710.500.430.470.560.39---
Deferred Revenue0.000.000.000.210.190.000.000.020.01
Other Current Liabilities1.170.880.070.140.140.460.180.090.05
Total Current Liabilities1.832.211.811.471.601.080.310.250.15
Non-Current Liabilities
Long-Term Debt1.870.210.200.210.200.210.270.190.16
Deferred Tax Liabilities0.100.040.020.020.010.010.000.010.00
Other Non-Current Liabilities0.050.090.170.280.560.380.060.000.00
Total Non-Current Liabilities2.010.370.460.530.800.660.320.250.21
Total Liabilities3.832.592.272.002.401.730.630.500.36
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.000.000.00
Retained Earnings-8.32-8.61-7.96-7.08-5.08-3.55-1.96-1.01-0.33
Accumulated Other Comprehensive Income-0.08-0.15-0.10-0.080.020.01-0.010.000.00
Additional Paid-in Capital12.7612.0911.6011.5411.197.412.932.741.00
Minority Interest0.000.000.000.000.000.000.020.010.01
Shares Outstanding1.441.381.351.361.33----
Total Stockholders' Equity4.363.333.544.386.133.870.961.750.68
Total Liabilities & Equity8.195.925.816.388.545.601.612.251.05

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BeOne Medicines Balance Sheet

How much debt does BeOne Medicines have?

BeOne Medicines had total debt of $2.00B as of Dec 31, 2025, against $4.55B in cash and short-term investments. Its debt-to-equity ratio was 0.46. Total debt was $1.08B a year earlier.

What are BeOne Medicines's total assets?

BeOne Medicines reported total assets of $8.19B as of Dec 31, 2025, up 38.3% from $5.92B a year earlier. Total liabilities were $3.83B.

What is BeOne Medicines's shareholders' equity?

BeOne Medicines's shareholders' equity was $4.36B as of Dec 31, 2025, or about $3.03 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition